|
Recommend Cancer Biology & Therapy to your librarian for 2008. Download the form here.
Sign up for Table of Contents Alerts. Table of ContentsJanuary 2008volume 7| issue 1 |
|
Editor's Corner
Cover Image
Volume: 7 | Issue: 1
Review
Biology of breast cancer bone metastasis
Mojtaba Akhtari, Junaid Mansuri, Kam A. Newman, Theresa M. Guise and Prem SethVolume: 7 | Issue: 1 | Pages: 3 - 9
Journal Club
HIF-1α and STAT3 client proteins interacting with the cancer chaperone Hsp90: Therapeutic considerations
Hanna Leah Kim, Marco Cassone, Laszlo Otvos Jr. and Paraskevi VogiatziVolume: 7 | Issue: 1 | Pages: 10 - 14
Clinical Study
Circulating biomarkers of bevacizumab activity in patients with breast cancer
Neelima Denduluri, Sherry X. Yang, Arlene W. Berman, Diana Nguyen, David J. Liewehr, Seth M. Steinberg and Sandra M. SwainVolume: 7 | Issue: 1 | Pages: 15 - 20
Commentary
Biomarkers in breast cancer
Heather McArthur and Maura DicklerVolume: 7 | Issue: 1 | Pages: 21 - 22
Research Paper
Genetic polymorphisms in OGG1 and their association with angiomyolipoma, a benign kidney tumor in patients with tuberous sclerosis
Samy L. Habib, Elaine Danial, Subrata Nath, Jennifer Schneider, Christopher P. Jenkinson, Ravindranath Duggirala, Hanna E. Abboud and Farook ThameemVolume: 7 | Issue: 1 | Pages: 23 - 27
The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment.
Vanina Medina, Máximo Croci, Ernesto Crescenti, Nora Mohamad, Francisca Sanchez-Jiménez, Noelia Massari, Mariel Nuñez, Graciela Cricco, Gabriela Martin, Rosa Bergoc and Elena RiveraVolume: 7 | Issue: 1 | Pages: 28 - 35
Commentary
Histamine in cancer: The two faces of the coin
Fabio Cianchi, Maria Cristina Vinci and Emanuela MasiniVolume: 7 | Issue: 1 | Pages: 36 - 37
Research Paper
MDM2 displays differential activities dependent upon the activation status of NFκB
Misty D. Cheney, Pamela P. McKenzie, Erin L. Volk, Liying Fan and Linda C. HarrisVolume: 7 | Issue: 1 | Pages: 38 - 44
Expression and significance of HERG protein in gastric cancer
Xiao-Dong Shao, Kai-Chun Wu, Xiao-Zhong Guo, Man-Jiang Xie, Jing Zhang and Dai-Ming FanVolume: 7 | Issue: 1 | Pages: 45 - 50
Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkins lymphoma cells
Zhi-Ming Li, Wen-Qi Jiang, Zhen-Yu Zhu, Xiao-Feng Zhu, Jun-Min Zhou, Zong-Chao Liu, Da-Jun Yang and Zhong-Zhen GuanVolume: 7 | Issue: 1 | Pages: 51 - 60
Commentary
Targeting Bcl-xL enhances the cytotoxicity of chemotherapeutics
Shulin WangVolume: 7 | Issue: 1 | Pages: 61 - 62
Research Paper
The role of p53 in the trafficking of copper-64 to tumor cell nuclei
Martin Eiblmaier, Laura A. Meyer and Carolyn J. AndersonVolume: 7 | Issue: 1 | Pages: 63 - 69
Downregulation of IgG Fc binding protein (FcγBP) in prostate cancer
Mozammel H. Gazi, MeiLan He, John C. Cheville and Charles Y.F. YoungVolume: 7 | Issue: 1 | Pages: 70 - 75
Bismuth-213 radioimmunotherapy with C595 antiMUC1 monoclonal antibody in an ovarian cancer ascites model
Emma Y. Song, Chang F Qu, Syed M.A. Rizvi, Chand Raja, Julia Beretov, Alfred Morgenstern, Christos Apostolidis, Frank Bruchertseifer and Alan PerkinsVolume: 7 | Issue: 1 | Pages: 76 - 80
Commentary
Targeting the human MUC1 oncoprotein: A tale of two proteins
Donald W. KufeVolume: 7 | Issue: 1 | Pages: 81 - 84
Research Paper
Modulation in the activity of lactate dehydrogenase and level of c-Myc and c-Fos by modified base queuine in cancer
Chandramani Pathak , Yogesh K. Jaiswal and Manjula VinayakVolume: 7 | Issue: 1 | Pages: 85 - 91
The effectiveness of retinoic acid treatment in bladder cancer: Impact on recurrence, survival and TGFα and VEGF as end-point biomarkers.
Diaa A. Hameed and Tarek H. El-MetwallyVolume: 7 | Issue: 1 | Pages: 92 - 100
Commentary
Prevention of bladder cancer recurrence by retinoic acid-ketoconazole
Yair Lotan and Rueben LotanVolume: 7 | Issue: 1 | Pages: 101 - 102
Research Paper
Development of Ad-mda7/IL-24-resistant lung cancer cell lines
Abujiang Pataer, Sunil Chada, Jack A. Roth, Kelly K. Hunt and Stephen G. SwisherVolume: 7 | Issue: 1 | Pages: 103 - 108
Commentary
Acquired and innate resistance to the cancer-specific apoptosis-inducing Cytokine, mda-7/IL-24: Not insurmountable therapeutic problems
Devanand Sarkar, Paul Dent, David T. Curiel and Paul B. FisherVolume: 7 | Issue: 1 | Pages: 109 - 112
Research Paper
Ciprofloxacin-induced G2 arrest and apoptosis in TK6 lymphoblastoid cells is not dependent on DNA double-strand break formation
Daniel J. Smart, H. Dorota Halicka, Frank Traganos, Zbigniew Darzynkiewicz and Gary M. WilliamsVolume: 7 | Issue: 1 | Pages: 113 - 119
hADA2a and hADA3 are required for acetylation, transcriptional activity and proliferative effects of beta-catenin
Min Yang, Marian L. Waterman and Rainer K. BrachmannVolume: 7 | Issue: 1 | Pages: 120 - 128
Commentary
hADA2a and hADA3: new players in ß-catenin signaling
Charles Lopez, Joshi Alumkal and Katy Van HookVolume: 7 | Issue: 1 | Pages: 129 - 130
Research Paper
The effect of fatty acid-CoA ligase 4 on the growth of hepatic cancer cells
Chuangying Hu, Liang Chen, Yong Jiang, Yi Li and Shaofeng WangVolume: 7 | Issue: 1 | Pages: 131 - 134
Allele-specific expression in the germline of patients with familial pancreatic cancer: An unbiased approach to cancer gene discovery
Aik Choon Tan, Jian-Bing Fan, Collins Karikari, Marina Bibikova, Eliza Wickham Garcia, Lixin Zhou, David Barker, David Serre, Georg Feldmann, Ralph H. Hruban, Alison P. Klein, Michael Goggins, Fergus J. Couch, Thomas J. Hudson, Raimond L. Winslow, Anirban Maitra and Aravinda ChakravartiVolume: 7 | Issue: 1 | Pages: 135 - 144
Oral administration of attenuated S. typhimurium carrying shRNA-expressing vectors as a cancer therapeutic
Nan Yang, Xiangying Zhu, Lishan Chen, Shenghua Li and Daming RenVolume: 7 | Issue: 1 | Pages: 145 - 151
Commentary
Salmonella typhimurium as a novel RNA interference vector for cancer gene therapy
Meenhard Herlyn and Devraj BasuVolume: 7 | Issue: 1 | Pages: 151 - 152




